Bonk (NASDAQ:BNKK) Trading Up 11.4% – Time to Buy?

Shares of Bonk, Inc. (NASDAQ:BNKK) traded up 11.4% during mid-day trading on Friday . The stock traded as high as $4.08 and last traded at $4.00. 84,142 shares were traded during trading, a decline of 98% from the average session volume of 4,055,819 shares. The stock had previously closed at $3.59.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Bonk in a research note on Monday, December 29th. Wall Street Zen raised Bonk to a “sell” rating in a report on Saturday, December 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Bonk Price Performance

The stock has a market cap of $21.04 million, a P/E ratio of -0.52 and a beta of 1.93. The business has a fifty day moving average of $4.04.

Bonk (NASDAQ:BNKK) last posted its earnings results on Wednesday, November 19th. The company reported ($3.85) EPS for the quarter. The business had revenue of $1.51 million during the quarter.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.